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Abstract
Chromosomal instability (CIN) is a hallmark of cancer and it results from ongoing errors in 
chromosome segregation during mitosis. While CIN is a major driver of tumor evolution, its role 
in metastasis has not been established. Here we show that CIN promotes metastasis by sustaining a 
tumor-cell autonomous response to cytosolic DNA. Errors in chromosome segregation create a 
preponderance of micronuclei whose rupture spills genomic DNA into the cytosol. This leads to 
the activation of the cGAS-STING cytosolic DNA-sensing pathway and downstream noncanonical 
NF-κB signaling. Genetic suppression of CIN significantly delays metastasis even in highly 
aneuploid tumor models, whereas inducing continuous chromosome segregation errors promotes 
cellular invasion and metastasis in a STING-dependent manner. By subverting lethal epithelial 
responses to cytosolic DNA, chromosomally unstable tumor cells co-opt chronic activation of 
innate immune pathways to spread to distant organs.
Chromosomal instability (CIN) correlates with tumor metastasis1,2, yet it remains unclear 
whether it is a mere bystander or a driver of metastatic progression. Chromosomally 
unstable cells exhibit evidence of chromosome missegregation during anaphase3,4, offering 
an attractive bottleneck to target CIN and probe its selective contribution in metastasis. 
Destabilization of microtubule attachments to chromosomes at the kinetochores, through 
overexpression of the non-motile microtubule depolymerizing kinesin-13 proteins, Kif2b or 
MCAK/Kif2c, directly suppresses CIN in otherwise chromosomally unstable cells5–7. Cells 
overexpressing Kif2b or MCAK continue to propagate abnormal aneuploid karyotypes albeit 
in a stable manner7. As such, this approach permits direct experimental interrogation of 
CIN, as defined by the rate of ongoing chromosome missegregation, independently of 
aneuploidy, which is defined as a state of abnormal chromosome numbers.
Increased CIN in human metastases
First, to determine whether CIN is associated with human metastases, we applied the 
weighted-genomic integrity index (wGII) as a proxy for CIN8 on 79 primary tumor-brain 
metastases matched pairs from a recently published cohort9. Metastases exhibited increased 
wGII compared to primary tumors (Fig. 1a, Extended Data Fig. 1a–b).
Next, karyotype analysis of primary breast tumors and metastases archived in the Mitelman 
Database of chromosomal translocations10 revealed a predilection for near-diploid (2n) 
karyotypes in primary tumors. Conversely, metastases were enriched for cells with near-
triploid (3n) karyotypes and had twice as many structural or numerical chromosomal 
aberrations per clone. The number of chromosomal aberrations was highest in tumor 
samples with karyotypes ranging between the diploid and tetraploid (4n) range (Fig. 1b–c 
and Extended Data Fig. 1c–d).
Finally, histologic analysis of primary tumors from patients with locally advanced head and 
neck squamous cell carcinoma11 revealed a significant association between anaphase 
chromosome missegregation and the incidence of lymph node metastasis (Fig. 1d, Extended 
Data Fig. 1e).
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CIN is a driver of metastasis
To determine whether CIN is causally involved in metastasis, we used transplantable 
metastatic tumor models of human (MDA-MB-231) or murine (4T1) triple-negative breast 
cancer and human lung adenocarcinoma (H2030), in which 47%, 55%, and 67% of anaphase 
cells, respectively, show evidence of chromosome missegregation. Overexpression of Kif2b 
or MCAK suppressed chromosome missegregation, whereas overexpression of a dominant 
negative MCAK mutant12 (dnMCAK) led to a modest increase in chromosome 
missegregation in MDA-MB-231 cells. Kinesin-13 overexpression did not alter cellular 
proliferation or the number of centrosomes per cell (Fig. 2a–b, Extended Data Figs. 1f–h and 
3a). As a control, we overexpressed Kif2a, a third member of the kinesin-13 proteins that 
lacks kinetochore and centromere localization domains13, and observed no effect on CIN 
despite exhibiting microtubule-depolymerizing activity on interphase microtubules (Fig. 2b, 
Extended Data Fig. 1i–j). We ruled out a direct role for kinesin-13-mediated microtubule 
depolymerization in activating small GTPases14 by performing RhoA and Rac1 pull-down 
assays, which revealed low basal levels of activity and no correlation with kinesin-13 
overexpression (Extended Data Fig. 2a–b). Hereafter, we refer to MCAK and Kif2b-
expressing cells as CIN-low while denoting control, Kif2a, and dnMCAK-expressing cells 
as CIN-high.
Karyotyping of the parental MDA-MB-231 cells revealed a widely aneuploid (~3n) 
chromosome content with widespread karyotypic heterogeneity (Extended Data Fig. 2c). 
Suppression of CIN reduced both numerical and structural karyotypic heterogeneity in 
single-cell derived clones as supported by the presence of fewer chromosomes exhibiting 
non-clonal structural abnormalities and decreased numerical chromosome heterogeneity in 
CIN-low cells (Extended Data Fig. 2c–h). Importantly, CIN-low cells maintained highly 
aneuploid karyotypes, yet they faithfully propagated them in a stable manner. Thus, by 
comparing chromosomally stable aneuploid cells to their chromosomally unstable aneuploid 
counterparts, we can experimentally examine the role of CIN, independently of aneuploidy, 
in metastasis.
We injected MDA-MB-231 cells into the left cardiac ventricles of athymic mice to enable 
systemic dissemination while tracking metastatic colonization using a bioluminescence 
reporter. Altering chromosome missegregation rates had a dramatic effect on colonization, 
whereby mice harboring CIN-high cells rapidly succumbed to metastatic disease with a 
median survival of 70 days. Conversely, mice injected with CIN-low cells exhibited lower 
metastatic burden and a median survival of 207 days. Many metastases from CIN-low cells 
waxed-and-waned and, at times, spontaneously resolved, whereas metastases from CIN-high 
cells involved multiple organs and rapidly progressed leading to death. Similar results were 
obtained after injection of lung adenocarcinoma H2030 cells (Fig. 2c–e and Extended Data 
Fig. 3b–c). Overexpression of the spindle assembly checkpoint protein, Mad2 in MCAK-
expressing cells partially rescued chromosome missegregation15, and correspondingly 
augmented metastasis (Fig. 2c and Extended Data Fig. 3f).
We performed orthotopic injections of MDA-MB-231 or 4T1 cells into the mammary fat pad 
of athymic or immune competent BALB/c mice, respectively, followed by surgical excision 
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of the primary tumor. Suppression of CIN had no effect on primary tumor implantation 
efficiency and even enhanced primary tumor growth in the 4T1 model. Yet, in both models, 
suppression of CIN significantly reduced spontaneous metastasis and prolonged survival 
(Extended Data Fig. 3d–e).
We then assessed chromosome missegregation in the injected cells as well as cells derived 
from primary tumors and metastatic colonies (Fig. 3a). We performed this analysis using 
MDA-MB-231 cells and two metastasis-competent xenografts (PDX) derived from patients 
with ER+ and TNBC. Regardless of the CIN status of the injected cells, the majority of 
metastases enriched for higher rates of chromosome missegregation, whereas cells derived 
from most primary tumors had significantly lower rates of CIN (Fig. 3b–d). For instance, 
when CIN-high cells (Fig. 3d, dnMCAK, blue bars) were injected in the mammary fat pad, 
chromosome missegregation rates decreased in the primary tumors (green bars) before 
increasing once more in metastases spontaneously arising within the same animal (orange 
bars).
CIN enriches for mesenchymal traits
Bulk RNA sequencing (RNA-seq) of CIN-low and CIN-high MDA-MB-231 cells revealed 
1,584 differentially expressed genes. Principle component analysis (PCA) and unsupervised 
clustering accurately separated samples according to their CIN status. Metastasis-related and 
epithelial-to-mesenchymal (EMT) gene sets were relatively enriched in CIN-high cells. The 
top 23 differentially expressed genes in CIN-high cells (referred to as CIN signature) 
predicted distant-metastasis-free survival (DMFS) in a meta-analysis16 as well as a 
validation cohort17 of patients with breast cancer, irrespective of tumor subtype, grade, or 
lymph node status (Extended Data Figs. 4 and 5).
RNA-seq of primary tumor-derived and metastasis-derived cells revealed pathways that were 
shared among metastases and CIN-high cells. Yet, metastases contained a large number of 
differentially upregulated EMT and inflammation-related genes that were disproportionately 
clustered on chromosome 1, signifying chromosome 1-specific selection. Karyotype analysis 
revealed that the injected cell lines and most metastases had three copies of chromosome 1, 
whereas primary tumors consistently had 2 copies. Thus chromosome 1 loss is a recurrent 
event during primary tumor growth in this model (Extended Data Figs. 4c–f and 5a–e).
We then performed single-cell RNA sequencing (scRNA-seq) on two CIN-low (Kif2b and 
MCAK) and one CIN-high (dnMCAK) MDA-MB-231 cell lines comprising a total of 6,821 
cells. Clustering of single cells using EMT genes successfully classified most cells based on 
their CIN-status and revealed a fraction of cells (primarily CIN-high) that was highly 
enriched in mesenchymal markers (Fig. 4a). Unsupervised graph-based clustering, based on 
all expressed genes, identified 12 phenotypically distinct subpopulations. One subpopulation 
was defined by increased expression of genes involved in EMT and metastasis (referred to as 
subpopulation ‘M’) and was concomitantly enriched for CIN signature genes. This 
subpopulation comprised 45% of dnMCAK expressing cells compared to 6% of the CIN-
low cells (Fig. 4b and Extended Data Fig. 6a–b).
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In line with the scRNA-seq data, CIN-high cells exhibited increased migratory and invasive 
behavior in vitro, and displayed evidence of actin cytoskeletal reorganization, diffuse 
vimentin staining, and increased cytoplasmic and nuclear localization of β-catenin 
(Extended Data Figs. 6c–d and 7a–d). Expectedly, Mad2 overexpression rescued invasion 
and migration of MCAK expressing cells. Furthermore, the ability of Kif2b or MCAK 
overexpression to suppress invasion in vitro was dependent on the cell cycle, as the addition 
of thymidine after transient transfection of either proteins abrogated this phenotype 
(Extended Data Figs. 6f, 7e–f and Supplementary Fig. 2).
CIN generates cytosolic DNA
To better define CIN-responsive pathways, we performed a gene-gene Pearson correlation 
analysis using scRNA-seq data and identified two large gene modules: module 1 was 
characterized by proliferative and metabolic pathways, whereas module 2 comprised EMT 
and inflammation gene sets (Fig. 5a). There was a strong positive correlation between 
inflammation-related, CIN signature, and EMT genes in the scRNA-seq and bulk RNA-seq 
data (Figs. 4b, 5b, and Extended Data Fig. 4b–c).
Induction of inflammatory pathways in response to CIN was unexpected and was 
reminiscent of a viral infection. We asked whether CIN might introduce genomic DNA into 
the cytosol, thereby eliciting cellular responses normally reserved for anti-viral 
immunity18,19. Exposure of genomic DNA to the cytosol can result from either primary 
nuclear or micronuclear envelope ruptures20–24. We performed live-cell imaging using a 
NLS-GFP reporter25 and found no correlation between CIN and the frequency of NLS-GFP 
leakage into the cytosol in unconfined conditions. There was even a trend for more efficient 
primary nucleus repair in CIN-high cells. CIN-high nuclei ruptured more frequently only 
during confined migration, and this was primarily attributed to their increased ability to go 
through a larger number of small constrictions (Extended Data Fig. 7g–j) that mimic 
confined migration during metastasis25.
Instead, CIN-high cells and those derived from metastases exhibited a higher preponderance 
of micronuclei compared with CIN-low or primary tumor-derived cells, respectively (Fig. 
5c–e, Extended Data Fig. 8a–c). To examine if rupture-prone20 micronuclei correlated with 
increased cytosolic DNA, we stained cells using two different anti-dsDNA antibodies after 
selective plasma membrane permeabilization and found increased cytosolic dsDNA and 
single-stranded DNA (ssDNA) in CIN-high cells. The dsDNA signal, which was distinct 
from mitochondrial staining, disappeared after treatment with double-strand-specific – but 
not single-strand-specific – nuclease and after overexpression of Dnase2, confirming the 
specificity of these antibodies (Fig. 5f, Extended Data Fig. 8d–h). Quantification of dsDNA 
levels after subcellular fractionation revealed a four-fold reduction in cytosolic DNA in CIN-
low compared to CIN-high cells (Fig. 5g). Whole-genome sequencing of subcellular 
fractions at 30x coverage confirmed the genomic origin of cytosolic DNA (not shown).
To determine whether missegregated chromosomes provide a source of cytosolic DNA, we 
employed an inducible Y chromosome-specific missegregation system established in 
chromosomally stable DLD-1 colorectal cancer cells26. Whole-chromosome FISH probes 
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targeting the Y chromosome or an independent autosome (chr15) revealed selective 
incorporation of the Y chromosome into micronuclei two days following chromosome 
missegregation induced by doxycycline and auxin (Dox/IAA) treatment. Strikingly, Y 
chromosome-specific fragments were found dispersed within the cytosol 2–3 days after 
Dox/IAA addition, whereas the control autosome remained confined to the nucleus (Fig. 
5h), demonstrating that cytosolic DNA is generated from chromosomes undergoing high 
rates of missegregation
Suppressing micronuclear envelope rupture through mCherry-Lamin B2 overexpression20 
reduced cytosolic dsDNA staining without influencing chromosome segregation errors. 
Accordingly, it reduced metastasis after intracardiac or tail vein injections (Fig. 5i and 
Extended Data Fig. 3g–h).
Metastasis from cytosolic DNA response
In chromosomally stable cells, cytosolic dsDNA is scarce and is sensed by the cGAS-
STING pathway19, leading to induction of type I interferon stimulated genes (ISGs)22,23,27. 
Indeed, induced missegregation of the Y chromosome led to the upregulation of OAS2, an 
ISG, and increased interferon-β production by DLD-1 cells (Extended Data Fig. 9f–g). It is 
unclear how chromosomally unstable cancer cells cope with the constant presence of 
cytosolic DNA. We found a striking localization of cGAS to approximately half of all 
micronuclei as previously observed22,23. Impeding micronuclear rupture through Lamin B2 
overexpression20 significantly diminished the relative fraction of cGAS+ micronuclei (Fig. 
6a–b). Furthermore, CIN-high cells exhibited increased levels and perinuclear localization of 
STING congruent with pathway activation (Fig. 6c).
Interestingly, there was no evidence for robust activation of downstream canonical NF-κB or 
type I interferon signaling in CIN-high cells as evidenced by the lack of a significant 
increase in p65 or IRF3 phosphorylation, absence of p65 or IRF3 nuclear translocation, 
undetectable levels of interferon-β, and failure to induce ISGs (Extended Data Figs. 8i–j and 
9), in line with previous observavtions28–30.
Cytosolic DNA, however, can activate the noncanonical NF-κB pathway in a STING-
dependent and TBK1-independent manner18. We found evidence for noncanonical NF-κB 
activation in CIN-high cells as revealed by lower levels of the precursor protein, p100, a 
trend toward higher ratios of p52 and phosphorylated p100 relative to total p100, as well as 
lower levels of the noncanonical NF-κB pathway inhibitor, TRAF231 (Extended Data Fig. 
8i–j). Given the subtle differences seen on the protein level, we assessed the nuclear 
localization of RelB, the binding partner of p52, and observed increased nuclear localization 
in CIN-high cells. This was often accompanied by cytosolic staining, indicative of chronic 
pathway activation. STING depletion reduced RelB nuclear localization and led to 
downregulation of EMT and inflammatory pathways, whereas the addition of cGAMP or 
overexpression of Mad2 increased nuclear RelB in MCAK-expressing cells (Fig. 6d, 
Extended Data Figs. 4e and 9c–e).
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Bulk RNA-seq data revealed a number of noncanonical NF-κB target genes that were 
upregulated in response to CIN (CIN-responsive NC-NF-κB genes). There was a robust 
correlation between the CIN signature, STING, and the CIN-responsive NC-NF-κB genes in 
scRNA-seq data, in contrast to a weaker correlation between CIN and type I interferon 
targets (Fig. 5b, Extended Data Fig. 6e). Similarly, RNA-seq data from primary breast 
cancer in the TCGA database demonstrated increased expression of CIN-responsive NC-NF-
κB genes in tumors with higher CIN signature genes (Fig. 6e) and higher expression of key 
regulators of the noncanonical NF-κB pathway or its CIN responsive target genes was 
associated with shorter DMFS and disease-free survival in breast and lung cancers. 
Conversely, increased canonical NF-κB or type I interferon regulatory factors were 
associated with an improved prognosis (Extended Data Fig. 10a).
cGAS activation by cancer cells has been invoked in brain metastasis through a non-tumor 
cell-autonomous manner32. We found that STING and downstream noncanonical NF-κB 
activity are mediators of metastasis in a tumor cell-autonomous fashion as evidenced by 
reduction in metastatic dissemination, lifespan extension, and reduction in in vitro and in 
vivo invasion in CIN-high cells depleted of STING, RelB, or p100 (NFKB2). Conversely, 
the addition of cGAMP increased invasion and migration of CIN-low cells (Fig. 6f–g, 
Extended Data Figs. 6f, 9j, and 10b-d). These findings are in line with reported roles for the 
noncanonical NF-κB pathway in EMT, cellular invasion, and metastasis33–35.
DISCUSSION
Our work reveals an unexpected link between CIN, chronic activation of cytosolic DNA 
sensing pathways, and metastasis. In addition to fueling karyotypic heterogeneity that serves 
as a substrate for natural selection, ongoing chromosome missegregation is required to 
replenish cytosolic DNA pools and to maintain cells in a pro-metastatic state. Consequently, 
suppressing CIN reduces metastasis even in highly aneuploid cells. The repercussions of 
STING activation are context-dependent and range from senescence to 
tumorigenesis21,27,28,30. Given that chromosomally unstable cells are awash with cytosolic 
DNA, we raise the interesting possibility that by suppressing downstream type I interferon 
signaling30 and instead upregulating the alternative NF-κB pathway, they have substituted a 
lethal epithelial response to inflammation with that of myeloid-derived cells36,37, thereby 
engaging in some form of immune mimicry. Restoring normal responses to inflammation 
would constitute a viable therapeutic strategy to target chromosomally unstable cells. The 
evolutionary benefits of the noncanonical pathway would justify the scarcity of inactivating 
mutations in cGAS and STING among breast and lung cancers (Extended Data Fig. 10e).
The emergence, and subsequent tolerance, of CIN represents an important bottleneck during 
tumor evolution38–40. We found that CIN induces a transcriptional shift from a proliferative 
and highly metabolic state, ideally suited for primary tumor growth, to a mesenchymal state 
associated with upregulation of inflammatory pathways (Figs. 4b and 5a). These two 
mutually exclusive states, which were recently observed in a pan-cancer genomic analysis of 
metastatic tumors41, likely account for the reversibility in chromosome missegregation rates 
seen in primary tumors and metastases, and provide an explanation for the negative effect of 
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aneuploidy during early tumorigenesis40,42. It also leads us to suggest that CIN drives the 
subset of human metastases characterized by EMT and inflammation41.
METHODS
Genomic analysis of Primary-metastasis matched pairs
Whole exome DNA sequence data from 79 brain metastases with matched primary tumor 
and normal9 was downloaded from the database of Genotypes and Phenotypes (dbGAP) and 
processed as described43 to derive allele specific segmented DNA copy number data for each 
sample. The weighted Genome Instability Index (wGII), describing the proportion of the 
genome that was classified as aberrant relative to tumor ploidy, was determined as 
described8.
Mitelman Database analysis
All available breast adenocarcinoma cases in the Mitelman database10 were analyzed. 
Primary literature was reviewed to determine the source of the sample (primary tumor or 
metastasis). When clonal karyotype was reported as a range, the average value was used for 
that given clone. Karyotype aberrations included structural aberrations as well as numerical 
deviations from the overall karyotype of the clone.
Analysis of chromosome segregation in HNSCC
We analyzed primary tumor specimens for 60 patients with head and neck squamous cell 
carcinoma (HNSCC)11. 40 patients had Hematoxylin and Eosin-stained (H&E) primary 
tumor samples of sufficient quality for high-resolution microscopy analysis. Analysis was 
restricted to cells fixed while undergoing anaphase as previously described44,45. 
Chromosome missegregation was defined by hematoxylin staining presence in between the 
remaining segregating chromosomes during anaphase and it was reported as the percentage 
of cells undergoing anaphase with evidence of chromosome missegregation as previously 
described44. Clinical lymph node status was defined on the basis of clinical examination or 
radiographic evidence of lymph node tumor involvement11.
Single-cell karyotyping
Cultures were treated with colcemid at a final concentration of 0.1μg ml−1. Following 45 
min incubation at 37°C, the cultures were trypsinized, resuspended in pre-warmed 0.075M 
KCl, incubated for an additional 10 minutes at 37°C and fixed in methanol-acetic acid (3:1). 
The fixed cell suspension was then dropped onto slides, stained in 0.08μg/ml DAPI in 
2xSSC for 5 minutes and mounted in antifade solution (Vectashield, Vector Labs). 
Metaphase spreads were captured using the Nikon Eclipse E800 epifluorescence microscope 
equipped with GenASI Cytogenetic suite (Applied Spectral Imaging, Carlsbad). For each 
sample a minimum of 20 inverted DAPI-stained metaphases were fully karyotyped and 
analyzed according to the International System of Human Cytogenetic Nomenclature 
(ISCN) 2013.
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Fluorescence in situ hybridization (FISH) analysis
FISH analysis was performed on fixed-cells prepared for single-cell karyotyping. Based on 
karyotype data, a total of four chromosomes were selected to further evaluate numerical 
instability. Probes specific for Centromere 3 (Red), Centromere 4 (Orange), and Centromere 
9 (Green) were purchased form Abbott-Vysis (Des Plaines, IL). Chromosome 6 centromeric 
probe was home-brew (PAC clone P308; labeled with Green dUTP, MSKCC Molecular 
Cytogenetics Core Facility. Probe labeling, hybridization, post-hybridization washing, and 
fluorescence detection were performed according to standard laboratory procedures. For 
each probe, three normal peripheral blood samples (GM07535, GM06875 and GM00558), 
obtained from Coriell Institute (Camden, New Jersey) were also analyzed to derive cut-off 
values (false-positive).
RhoA and Rac1 pull-down assays
The activity of RhoA and Rac1 was determined according to the bead-based pull-down 
assay kits (Cytoskeleton Inc., RhoA: BK036S, Rac1: BK035S). Cells were lysed on the 
tissue culture dish and rapidly snap frozen until further processing. cGAMP was added for 
18 hours prior to lysis. In addition to His-tagged RhoA and Rac1, the positive and negative 
controls were total cell lysates supplanted with non-hydrolysable GTP or GDP, respectively.
Cell culture
Cell lines were purchased from the American Type Culture Collection (ATCC). Tumor 
(MDA-MB-231, 4T1, HEK293, and H2030), cells were cultured in DMEM or RPMI (4T1) 
supplemented with 10% FBS and 2mM of L-Glutamine in the presence of penicillin (50 
Uml−1) and streptomycin (50 μgml−1). All cells tested negative for mycoplasma. Cell 
confluence was measured using IncuCyte live-cell analysis system (Essen Bioscience).
Immunofluorescence microscopy
Cell fixation and antibody staining were performed as previously described7. Briefly, cells 
were fixed with ice-cold (−30 C) methanol for 15 minutes – when staining for centromeres, 
centrosomes, cGAS, Vimentin, β-actin, IRF3, or a-tubulin – or 4% paraformaldehyde – 
when staining for RelB, p65, STING, ssDNA, dsDNA, CoxIV, or β-catenin. Subsequently, 
cells were permeabilized using 1% triton for 4 minutes. See supplementary Table 1 for 
antibody information. For selective plasma membrane permeabilization used for cytosolic 
dsDNA and ssDNA staining, cells were treated with 0.02% saponin for 5 minutes after 
fixation. For single-stranded (Thermo Fisher FEREN0321) and double stranded (Life 
Technologies – EN0771)-specific nuclease treatment, cells were also permeabilized with 
0.02% saponin for 2 minutes and treated with either nucleases for 10 minutes before fixation 
using 4% paraformaldehyde. TBS-BSA was used as a blocking agent during antibody 
staining. DAPI was added together with secondary antibodies. Cells were mounted with 
Prolong Diamond Antifade Mountant (Life Technologies – P36961). cGAMP (Invivogen – 
tlrl-nacga23) was transfected into cells at a concentration of 4μg/ml using lipofectamine2000 
that was added for 3–4 hours and then replaced with regular serum containing medium.
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Immunoblotting
Cells were pelleted and lysed using RIPA buffer. Protein concentration was determined 
using BCA protein assay and 20–30μg of total protein were loaded in each lane. Proteins 
were separated by gradient SDS-PAGE and transferred to PVDF or nitrocellulose 
membranes. Full blots are shown in Supplementary Fig. 1. See Supplementary Table 2 for 
antibody information. Band intensities on immunoblots were obtained using ImageJ 
(www.imagej.nih.gov/ij) or the LI-COR Odyssey software, normalized to loading control 
and background was subtracted. Ratios were normalized to control cells. Interferon-β levels 
from conditioned media were measured using the Human IFN beta Array 1-plex (Eve 
Technologies – HIFNB-01-31).
Y chromosome missegregation and fluorescent in situ hybridization (FISH)
Flp-In T-REx DLD-1 cells were engineered to express the TIR1 auxin-dependent plant E3 
ligase, an auxin-inducible degron (AID)-tagged CENP-A modified at the endogenous allele 
(CENP-AAID/–), and a doxycycline-inducible CENP-AC–H3 rescue gene integrated into the 
Flp-In locus as previously described26. 4.0 × 104 cells were seeded into 4-well chamber 
slides and treated with doxycycline (DOX, Sigma) and indole-3-acetic acid (IAA, Sigma) 
for up to 3 days to induce Y chromosome missegregation and micronuclei. Slides were 
washed in PBS, fixed in 3:1 methanol:acetic acid for 15 minutes at room temperature, and 
dehydrated with 80% ethanol. Chromosome paint FISH probes targeting chromosome Y and 
15 (MetaSystems) were mixed at equal ratios, applied to cells, sealed with a coverslip, and 
co-denatured at 75°C for 2 minutes followed by overnight hybridization at 37°C in a 
humidified chamber. Slides were washed in 0.4x saline–sodium citrate (SSC) buffer for 2 
minutes at 72°C, followed by a 30 second wash in 2x SCC, 0.05% Tween-20 buffer at room 
temperature. Cells were counterstained with DAPI and captured on a DeltaVision Elite (GE 
Healthcare) microscope system at 60x magnification (25 × 0.2 μm z-stacks) followed by 
image deconvolution and maximum intensity quick projection.
Knockdown and overexpression constructs
Luciferase expression was achieved using pLVX plasmid (expressing tdTomato) and cells 
stably expressing luciferase were selected using hygromycin and sorted for tdTomato 
expression. Kinesin-13 expression was achieved using plasmid (pEGFP) transfection or 
lentiviral (pLenti-GIII-CMV-GFP-2A-Puro) expression where cells were selected using 
G418 (0.5mgml−1) or puromycin (5μgml−1), respectively. Dnase2 overexpression was 
achieved using a pLenti-GIII-CMV-RFP-2A-Puro plasmid with puromycin used for 
selection. Plasmids containing kinesin-13 or Lamin B2 (pQCXIB-mCherry-lmnb2) 
constructs were kindly offered by the Compton and Hetzer Laboratories, respectively. 
Blasticidin was used to select for lmnb2 expressing cells at 10μgml−1. All other plasmids 
were purchased from Applied Biological Materials Inc. (www.abmgood.com). Stable 
knockdown of STING, NFKB2, RelB, and cGAS were achieved using shRNAs in pRRL 
(SGEP or SGEN) plasmids and were obtained from the MSKCC RNA Interference Core. 2–
4 distinct shRNA hairpins were screened per target. Targeted shRNA sequences are listed in 
Supplementary Table 3. To visualize primary nuclear rupture, cells were stably modified 
with retroviral construct expressing both NLS-GFP25 and H2B-Tdtomato (3xNLScopGFP-
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P2A-H2BtdTomato-IRES-Puromycin). Cells were cultured for 24 hours after viral 
transduction before selection with 1μg ml−1 of Puromycin and subsequently sorted to select 
for NLS-GFP and H2B-TdTomato expression.
Cell migration in microfluidic devices
Microfluidic migration devices with precisely defined constrictions were prepared as 
described previously25,46. Devices were coated with 50 μg/mL of type-I rat tail collagen (BD 
Biosciences) in 0.02N acetic acid overnight at 4°C. Approximately 80,000 cells were seeded 
(in DMEM supplemented with 10% FBS and 1% PenStrep) per migration chamber. Devices 
were placed in a tissue-culture incubator (37°C) for 5–6 hours to allow the cells to adhere. 
Subsequently, media was changed to phenol-red free Leibovitz L15 media supplemented 
with 10% FBS and 1% PenStrep before mounting the device on an inverted microscope 
(Zeiss Observer Z1) equipped with temperature-controlled stage (37°C) for live-cell 
imaging. The media reservoirs of the device were covered with glass coverslips to minimize 
evaporation during live-cell imaging. Cells were imaged for 14–16 hours at 10 minute 
intervals with a CCD camera (Photometrics CoolSNAP KINO) using a Zeiss 20′/NA 0.8 air 
objective. Acquired image sequences were analyzed for nuclear rupture frequency, duration, 
and transit time of cells through 1×5μm2, 2×5μm2, and 15×5μm2 constrictions using Zen 
(Zeiss) software and a custom-written MATLAB 2016a script for automated image analysis.
Animal studies
Animal experiments were performed in accordance with protocols approved by the Weill 
Cornell Medicine Institutional Animal Care and Use Committee. For disease-specific 
survival in MDA-MB-231 experiments, power analysis indicated that 10 mice per group will 
be sufficient to detect a difference at relative hazard ratios of <0.2 or >5 with 80% power 
and 95% confidence, given a median disease-specific survival of 3 months in the control 
group and a total follow up period of 250 days. For the 4T1 experiments, Power analysis 
indicates that 10 mice per group will be sufficient to detect a difference at relative hazard 
ratios of <0.25 or >4.0 with 80% power and 95% confidence, given a median survival of 58 
days in the control group and a total follow up period of 180 days. There was no need to 
randomize animals. Investigators were not blinded to group allocation. Intracardiac injection 
was performed as previously described32. Briefly, cells were trypsinized and washed with 
PBS and a 1×105 cells (in 100 μl of PBS) were injected into the left cardiac ventricle of 
female athymic 6–7 week old athymic nude (nu/nu) mice (Jackson Laboratory strain 
002019). 2×105 cells were injected into the tail vein cohort of animals. Mice were then 
immediately injected with D-luciferin (150 mgkg−1) and subjected to bioluminescence 
imaging (BLI) using tan IVIS Spectrum Xenogen instrument (Caliper Life Sciences) to 
ensure systemic dissemination of tumor cells. Metastatic burden was measured 5–7 weeks 
after injection using BLI. BLI images were analyzed using Living Image Software v.2.50. 
Disease-specific survival endpoint was met when the mice died or met the criteria for 
euthanasia under the IACUC protocol and had radiographic evidence of metastatic disease. 
For orthotopic tumor implantation, 2.5×105 cells in 50μl of PBS were mixed 1:1 with 
Matrigel (BD Biosciences) and injected into the fourth mammary fat pad. Only one tumor 
was implanted per animal. MDA-MB-231 primary tumors were surgically excited before 
they reached ~1.5 cm in the largest dimension (which was the maximum allowable under 
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our IACUC protocol) and metastatic dissemination was assessed using BLI imaging at 1–3 
week intervals for up to 30 weeks. Distant metastasis-free survival endpoint was met when 
BLI signal was seen outside of site of primary tumor transplantation. 4T1 tumors were 
excised 8–9 days after implantation. To derive short-term culture from primary tumors and 
metastases, anesthetized animals (isofluorane) were imaged then sacrificed. Ex-vivo BLI 
was subsequently performed on harvested organs to define the precise location of the 
metastatic lesion. Primary tumors and metastases were subsequently mechanically 
dissociated and cultured in DMEM with selection media (G418 or hygromycin) to select for 
tumor cells and exclude host cells. All subsequent assays (karyotyping, RNAseq, 
immunofluorescence, and subcellular fractionation) were performed after a single passage 
from the primary sample. To assess chromosome missegregation from primary tumor-
derived and metastases-derived cells, we performed high-resolution immunofluorescence 
analysis on passage #1 cells, staining for DNA (DAPI) and centromeres (ACA). Cells with 
DNA or centromere staining in the middle of the anaphase plate was taken as evidence of 
chromosome missegregation.
Patient-derived xenografts (PDX) assays
PDX models of human metastatic breast cancers were generated by transplanting the freshly 
obtained surgically excised tumor specimens from patients consented under the IRB 
approved protocol (MSKCC IRB #97-094) in female NOD-scid IL2Rgammanull (NSG) 
(Jackson Laboratories strain 005557). All relevant ethical regulations were followed. The 
estrogen receptor-positive PDX was derived from breast cancer metastatic to the bone. The 
TNBC PDX was established out of an axillary lymph node metastasis from a patient with 
inflammatory breast cancer. PDXs were maintained for a maximum of three serial passages. 
Briefly, freshly obtained tumor tissue specimens were either directly transplanted in the 
mammary fat-pad of the mice or minced into 1–2 mm pieces in serum free MEM medium 
with nonessential amino acids (Cat# 41500018, Thermofisher) transduced with lentiviral 
vectors expressing either GFP-luciferase or pUltra-Chili-Luc plasmid (Addgene plasmid: 
48688) followed by transplantation into mice. Typically PDX tumor growth became evident 
during the first 1–3 weeks post engrafting and tumor continued to grow for additional 4–8 
weeks. Primary tumor growth and metastases were followed using BLI or spectrum CT 
imaging. At the time of harvesting of primary tumors and metastases, we derived primary 
cell cultures directly from primary tumors as well as lung and liver metastases. Briefly, 500 
mg of fresh bulk tumor tissues were chopped into 1–2 mm3 sized pieces and incubated in 
Accutase (AT104; Innovative Cell Technologies) for cell detachment and separation over 1–
2 hours. The dissociated tissues were sieved through 100-μm cell strainers and pelleted the 
cells by centrifugation at 1200 RPM. The pellets were washed and resuspended in the above 
MEM buffer with 3% FBS. Cells were analyzed for chromosome missegregation after one 
passage.
RNA sequencing and analysis
Bulk RNA was extracted from cells using the QIAShredder (Qiagen – 79654) and the RNA 
extraction kit (Qiagen – 74106) and sequenced using HiSeq2500 or HiSeq4000 (Illumina 
Inc.). The quality of the raw FASTQ files were checked with FastQC (https://
www.bioinformatics.babraham.ac.uk/projects/fastqc/). For samples originating from mouse 
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xenografts, FASTQ reads were classified as originating from either mouse (GRCm38) or 
human (GRCh38) genomes using xenome47, and human-specific reads were used for 
mapping. Reads were mapped to human reference GRCh38 using STAR (v2.4.1d, 2-pass 
mode)48. Gene expression was estimated using cufflinks (v2.2.1, default parameters) and 
HTSeq (v0.6.1)49,50. Differential expression analyses were performed using DESeq2 
(v1.14.1)51. Pre-ranked gene set enrichment analyses (GSEA) was performed on the 
DESeq2 log2 fold changes52. Prior to any unsupervised analyses, expression counts were 
transformed using variance stabilizing transformation using the DESeq2 R package. Gene 
signatures used in the study are listed in Supplementary Table 5. Differentially expressed 
gene sets and their associated statistics are listed in Supplementary Table 6. To detect 
potential copy number changes, positional gene enrichment analysis (PGE) was performed 
on the up-regulated and down-regulated differentially expressed genes, separately (padj ≤ 
0.1)53. Only significant regions with 4 or more genes and with p-value ≤ 0.01 were kept for 
further analysis. Circos plots were made using the circlize R package54.
Reverse-transcriptase quantitative polymerize chain reaction (RT-qPCR)
Cells were collected into trizol® reagent (thermofisher) and total RNA was extracted using 
‘Pureling RNA mini kit’ (thermofisher) according to manufacturer’s instructions. 5ug of 
total RNA was used in reverse transcriptase polymerase chain reaction performed using 
‘RNA to cDNA Ecodry™ premix (oligo dT)’ cDNA synthesis kit (Clontech) according to 
manufacturers instructions. Resulting cDNA corresponding to 50ng of total RNA was used 
in each 20ul of quantitative real time PCR reaction. qRT-PCR was performed using 
SybrGreen master mix (Biorad) and the relative expression of each gene was calculated after 
normalizing to β-Actin endogenous control and using comparative ΔCt method. A list of the 
primers used is in Supplementary Table 4.
Single-cell RNA sequencing
Cells were trypsinized and resuspended in PBS. 21μl of a cellular suspension at 400 cells/ul, 
>95% viability, were loaded onto to the 10X Genomics Chromium platform to generate 
barcoded single-cell GEMs. Single-cell RNA sequencing (scRNA-seq) libraries were 
prepared according to 10X Genomics specifications (Single Cell 3′ Reagent Kits User 
Guide PN-120233, 10x Genomics, Pleasanton, CA, USA). GEM-Reverse Transcription (RT) 
(55°C for 2h, 85°C for 5min; held at 4°C) was performed in a C1000 Touch Thermal cycler 
with 96-Deep Well Reaction Module (Bio-Rad, Hercules). After RT, GEMs were broken and 
the single-strand cDNA was cleaned up with DynaBeads MyOne Silane Beads (Thermo 
Fisher Scientific, Waltham, MA) and SPRIselect Reagent Kit (0.6 × SPRI; Beckman 
Coulter). cDNA was amplified for 14 cycles using the C1000 Touch Thermal cycler with 96-
Deep Well Reaction Module (98°C for 3min; 98°C for 15s, 67°C for 20s, and 72°C for 1min 
× 14 cycles; 72°C for 1min; held at 4°C). Quality of the cDNA was analysed using an 
Agilent Bioanalyzer 2100 (Santa Clara, CA). The resulting cDNA was sheared to ~200bp 
using a Covaris S220 instrument (Covaris, Woburn, MA) and cleaned using 0.6 x SPRI 
beads. The products were end-repaired, ‘A’-tailed and ligated to adaptors provided in the kit. 
A unique sample index for each library was introduced through 10 cycles of PCR 
amplification using the indexes provided by in the kit (98°C for 45 s; 98°C for 20s, 60°C for 
30s, and 72°C for 20 s x 14 cycles; 72°C for 1min; held at 4°C). After two SPRI cleanups, 
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libraries were quantified using Qubit fluorometric quantification (Thermo Fisher Scientific, 
Waltham, MA) and the quality assessed on an Agilent Bioanalyzer 2100. Four libraries were 
pooled and clustered on a HiSeq2500 rapid mode at 10pM on a pair end read flow cell and 
sequenced for 98 cycles R1, followed by 14bp I7 Index (10X Barcode), 8bp I5 Index 
(sample Index) and 10bp on R2 (UMI). Primary processing of sequencing images was done 
using Illumina’s Real Time Analysis software (RTA). Demultiplexing and post processing 
was done using the 10X Genomics Cell Ranger pipeline as per the manufacturer 
recommendations. Single cell RNA sequencing data (scRNA-seq) was processed from raw 
reads to a molecule count array using the Cell Ranger pipeline55. Additionally, to minimize 
the effects of experimental artifacts on the analysis, data was pre-processed to filter out cells 
with low total molecule counts (library size), low complexity and high mitochondrial 
content, identified by a bimodal fit. Remaining cells were normalized by dividing the 
expression level of each gene in a cell by its total library size and then scaling by the median 
library size of all cells). After normalizing by library size; we performed principal 
component analysis (PCA) to improve robustness of the constructed Markov Matrix 
generated when computing diffusion eigenvalues for imputation of dropout noise56. We 
chose the number of principle components to retain approximately 80% of variance in the 
data and excluded the first principal component, which was highly correlated with library 
size. Imputation of both he normalized and unnormalized count matrix was performed using 
a Markov matrix raised to the power of 3 (power corresponds the approximate number of 
weighted nearest neighbors) and with a gene expression distribution computed according to 
21 nearest neighboring cells as described56. Our analysis was robust to imputation and we 
obtained similar results without imputed data (not shown). Subpopulations were identified 
using Phenograph57 and genes differentially expressed in at least one subpopulation were 
identified by the Kruskal-Wallis rank statistic using a bootstrapping method for random 
downsampling of matched molecule and cell counts from each subpopulation. t-Distributed 
Stochastic Neighbor Embedding (t-SNE) was used to visualize subpopulation structure 
based on the first 20 principle components of the imputed count matrix, subsetted by the top 
5,150 differentially expressed genes (FDR q of Kruskal Wallis rank statistic < 0.05). Mean 
expression of key gene signatures in population M versus other subpopulations were z-
normalized and visualized by violin plots. All gene signatures are annotated in 
Supplementary Table 5. The correlation between gene signatures was computed using the 
Spearman Rank Correlation Coefficient according to mean expression of all genes per 
signature per cell. Ward’s minimum variance method was applied to hierarchically cluster 
cells by their normalized expression of differentially expressed EMT genes.
Patient survival analysis
Genes used for survival analysis are listed in Supplementary Table 5. For the meta-analysis 
cohort, we used aggregate data from KMPlot (www.kmplot.com)16,58 using only JetSet best 
probe set and auto-selection for best cutoff between the 25th and 75th percentile. For the 
validation cohort in which DMFS data was available17, we used the z-normalized expression 
data for a dataset and the median value was used as a cutoff. DMFS curves were compared 
using the log-rank test.
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In vitro invasion and migration assays
For the invasion and migration/chemotaxis assays we used the CytoSelect cell invasion 
(CBA-110) and cell migration (CBA-100) kits, respectively. Briefly, 3×105 cells were 
suspended in serum-free media and placed on top of the membrane. Media containing serum 
was placed at the bottom and cells, which have invaded to the inferior surface of the collagen 
membrane, were stained and counted 18–24 hours later. For experiments involving transient 
transfection, cells were transfected, and thymidine (2mM) was added 18 later. Cells were 
plated on the membrane 3 days after transfection. For the chemotaxis assay, we used a 
colorimetric approach (OD 560nm) for quantification. For the scratch assay, cells were 
treated with mitomycin C (10 μgml−1) for 1 hour when they reached >90% confluence and 
then placed in DMEM containing 1% FBS. Wounds were applied using p200 pipette tip and 
images of the wound were taken immediately and at subsequent regular intervals. ImageJ 
was used for quantification of wound surface area.
Quantification of cytosolic DNA
Approximately 1×107 cells were lysed and the nuclear, cytosolic, and mitochondrial 
fractions were obtained using the mitochondrial isolation kit (Thermo Fisher – 89874). 
Protease inhibitors were not used to enable subsequent DNA purification. Mitochondria 
were purified at 12,000xg to minimize their contamination in the cytosolic fraction. DNA 
was subsequently isolated from the nuclear, cytosolic, mitochondrial fractions using the 
Qiagen DNeasy blood and tissue kit (Qiagen – 69506) and dsDNA was quantified using 
Qubit 2.0 (Invitrogen) using Qubit dsDNA HS Reagent.
Code availability
All custom code, statistical analysis, and visualizations were performed in Python or R, and 
used Nextflow to manage some of the computational pipelines59. Code for the RNA 
sequencing analysis is available online at: https://github.com/murphycj/manuscripts/tree/
master/BakhoumEtAl2017. The live-cell tracking MATLAB 2016a code can be found at 
https://github.com/Lammerding/MATLAB-CellTracking
Data availability
Source data for figures 1–3, 5–6, and Extended Data figures 1–3 and 5–10 are provided with 
the paper. Single-cell RNA sequencing data (shown in figures 4–5 and Extended Data figure 
6) was deposited in the Sequence Read Archive under the following accession number: 
SRP104750 (ftp://ftp-trace.ncbi.nlm.nih.gov/sra/review/
SRP104750_20170426_131604_b0888d686e89bf883fe90b85c9220b47). Bulk RNAseq data 
(shown in Extended Data figures 4–5) was deposited in Gene Expression Omnibus under 
accession number GSE98183 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?
acc=GSE98183)
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Extended Data
Extended Data Figure 1. Generation of isogenic tumor models of CIN
a, Weighted genomic instability index (wGII) of brain metastases as a function of the wGII 
of the matched primary tumor. Red line represents linear regression, n = 79 patients. b, 
Differences in wGII between metastases and matched primary tumors. RCC, renal cell 
carcinoma, the “Other” category includes melanoma, sarcoma, ovarian, thyroid, and salivary 
gland cancers. c, Number of clones (based on single-cell karyotypes) in primary breast 
tumors (n = 637) or metastases (Mets, n = 131) found in the Mitelman Database, boxes 
represent median ± interquartile range and bars span the 10th and 90th percentile, 
significance tested using two-sided Mann Whitney test. d, The number of chromosome 
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aberrations per clone as a function of the total number of chromosomes in a given clone in 
samples derived from primary breast tumor clones (n = 983) and metastatic clones (n = 186), 
data points represent average ± SD. e, Percentage of N− or N+ patients as a function of 
chromosome missegregation frequency (n = 20 patients per condition), significance tested 
using two-sided Fisher Exact test. f, Immunoblots of cells expressing various GFP-tagged 
kinesin-13 proteins stained using anti-GFP antibody, β-actin used as a loading control, 2 
independent experiments. g, Cellular confluence as a function of time of MDA-MB-231 
cells expressing various kinesin-13 proteins or dnMCAK expressing cells depleted of 
components of the cytosolic DNA-sensing machinery or the noncanonical NF-κB pathway, 
data points represent mean ± SD, n = 4 independent experiments. h, Left, MCAK and 
dnMCAK expressing cells stained for microtubules (DM1A), centrosomes (pericentrin) and 
DNA (DAPI), scale bar 5-μm, 2 independent experiments. Right, Frequency distribution of 
the number of pericentrin foci per cells. Significance tested using ANOVA. n = 100 cells per 
condition, 2 independent experiments. i, Cells expressing kinesin-13 proteins stained for 
microtubules (DM1A), centrosomes (pericentrin) and DNA (DAPI), scale bar 50-μm, 2 
independent experiments. Bottom-right, Fluorescence normalized to cell count of MDA-
MB0-231 cells expressing kinesin-13 proteins, bars represent mean ± s.e.m., * p < 0.05, 
two-sided t-test, n = 10 high-power fields encompassing 477–612 cells, 2 independent 
experiments.
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Extended Data Figure 2. Karyotype analysis of human tumor cells
a–b, Immunoblots showing total Rac1 (a) or RhoA (b) levels as well as Rac1 or RhoA that 
were pulled-down using antibodies that were specific to the GTP-bound form of Rac1 (a) or 
RhoA (b). Positive and negative controls were total MDA-MB-231 cell lysates supplanted 
with non-hydrolysable GTP (nhGTP) or GDP, respectively. β-actin was used as a loading 
control, 2 independent experiments. c–e, Representative karyotypes (DAPI-banding) from 
parental MDA-MB-231 cells (c), or populations derived from single MCAK (d) or Kif2a (e) 
expressing cells that were allowed to divide for 30 days. f, The number of non-clonal 
(present in <25% of the cells in a single clone) structurally abnormal chromosomes in CIN-
low or CIN-high MDA-MB-231 cells. ‘Mar’ denotes chromosomes so structurally abnormal 
that precludes their unambiguous identification by conventional banding, bars represent 
mean ± SD, n = 140 cells from 7 clonal populations, significance tested using two-way 
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ANOVA test. g, Examples taken from 4 distinct cells belonging to the same clonal 
population – derived from a single Kif2a-expressing cell – showing convergent 
translocations involving chromosome 22 with four other chromosomes. h, Deviation from 
modal chromosome number in single-cell-derived clones grown for 30 days. Four 
chromosomes were assayed for each clone using centromere-specific probes, *p < 0.05, **p 
< 0.005 compared to control clone 4, two-sided c2-test, n = 300 cells per clone. Diploid 
controls were used to determine false positive rate of the centromeric probes.
Extended Data Figure 3. CIN promotes formation and maintenance of metastasis
a, Chromosome missegregation in H2030 and 4T1 cells expressing kinesin-13 proteins. Bars 
represent mean ± SD, n = 150 cells, 3 independent experiments, significance tested using 
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two-sided t-test. b, Left, Normalized photon flux over time of whole animals injected with 
MDA-MB-231 cells expressing kinesin-13 proteins Bars represent mean ± s.e.m. n = 8 
(MCAK), 7 (Kif2b), 5 (Control), 4 (Kif2a), and 9 (dnMCAK) mice per group, 3 independent 
experiments. Right, Mice injected with MDA-MB-231 cells expressing dnMCAK (above) or 
Kif2b (below) where disease burden was tracked using BLI, 3 independent experiments. c, 
Photon flux (p/s) of whole animals imaged 5 weeks after intracardiac injection with control 
or MCAK expressing H2030 cells. Bars represent the mean, significance tested using two-
sided Mann Whitney test, n = 10 mice in the MCAK group and 5 mice in the control group. 
d, Left, Representative BLI images from two independent experiments of mice 
orthotopically transplanted with MDA-MB-231 cells before (Day 33) and after (Day 90) 
tumor excision. Metastasis can be detected in the mouse transplanted with dnMCAK 
expressing cells at day 90. Middle, Total flux (p/s) emitted from primary tumors 52 days 
after transplantation. Bars represent mean ± SD, n = 5 (CIN-low) and 14 (CIN-high) mice, p 
= 0.13, two-sided Mann Whitney test. Right, Distant metastasis-free survival (DMFS) of 
mice orthotopically transplanted with MDA-MB-231 cells with various levels of CIN. n = 15 
(CIN-low) and 29 (CIN-high) mice, pairwise significance tested with two-sided log-rank 
test. e, Tumor volume at 8 days (top) and survival (bottom) of mice transplanted with murine 
4T1 cells in the mammary fat pad. Bars represent median ± interquartile range, pairwise 
significance tested with two-sided t-test (top) and two-sided log-rank test (bottom). n = 20 
(CIN-low) and 30 (CIN-high) mice. f, Top, immunoblots of MCAK or MCAK and mad2 
overexpressing MDA-MB-231 cells stained for mad2 using anti-mad2 antibody with a-
tubulin used as a loading control, 3 independent experiments. Bottom, Percentage of 
anaphase cells exhibiting evidence of chromosome missegregation in MCAK or MCAK and 
mad2 overexpressing cells, bars represent mean ± SD, n = 150 cells, 3 experiments, 
significance tested using two-sided t-test. g, Top, immunoblots of dnMCAK or dnMCAK 
and Lamin B2 overexpressing MDA-MB-231 cells stained for Lamin B2 using anti-Lamin 
B2 antibody with β-actin used as a loading control, 2 experiments. Bottom, Percentage of 
anaphase cells exhibiting evidence of chromosome missegregation in dnMCAK or dnMCAK 
and Lamin B2 overexpressing cells, bars represent mean ± SD, n = 150 cells, 3 experiments, 
significance tested using two-sided t-test. h, Photon flux (p/s) of whole animals after 
intracardiac (left) or tail vein (right) injection with dnMCAK or dnMCAK and Lamin B2 
expressing MDA-MB-231 cells. Bars represent the median, significance tested using two-
sided Mann Whitney test, n = 9 (dnMCAK), 15 (dnMCAK and Lamin B2) mice in the 
intracardiac injection cohort and 5 mice per group in the tail vein injection cohort.
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Extended Data Figure 4. Transcriptional consequences of CIN in cancer cells
a–b, Principle component analysis (PCA) (left) and unsupervised clustering (right) of 5 
MDA-MB-231 cell lines expressing different kinesin-13 proteins based on bulk RNA 
expression data. b–e, Gene set enrichment analysis (GSEA) results showing HALLMARK 
gene sets that are highly enriched in CIN-high (control, Kif2a, and dnMCAK) compared 
with CIN-low cells (MCAK and Kif2b) cells (b–c) or STING-depleted cells (e), or after 
comparing metastases with primary tumors (d), significance tested using one-sided Weighted 
Smirnov-Kolmogorov test corrected for multiple tests. f, Heatmap of consensus 
chromosomal karyotypes of cells derived from primary tumors and metastases showing 
selective increase in chromosome 1 copy number in metastases compared with primary 
tumors.
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Extended Data Figure 5. Prognostic impact of the CIN signature
a, Volcano plot showing differentially expressed genes between CIN-high and CIN-low 
MDA-MB-231 cells. Red data points denote genes subsequently used for determining the 
CIN signature. b–e, Enrichment plots for all differentially expressed genes (a) or those on 
Chromosome 1 (d–e). Circos plot (c) showing genomic location (outer circle), log2-fold 
expression of genes significantly differentially expressed in metastases compared to primary 
tumors (middle circles), and the log10(p value, inner circle) for genomic amplifications (red) 
or deletions (blue) in metastases relative to primary tumors. n = 2 (CIN-low), 3 (CIN-high), 
11 (primary tumors), 28 (metastases). Significance tested using two-sided Wald test (a), one-
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sided Weighted Smirnov-Kolmogorov test (b, d, e), and one-sided hypergeometric test (c) all 
corrected for multiple testing. f–g, DMFS of breast cancer patients stratified by lymph node 
status, grade, and receptor status, from a meta-analysis (f, n = 664 patients) or a validation 
cohort (g, n = 171 patients) divided based on their average expression of the CIN gene 
expression. Significance tested using two-sided log-rank test.
Extended Data Figure 6. Single-cell sequencing and population detection
a, The cellular composition of every subpopulation presented Figure 4b. b, Violin plots 
showing expression probability density of key metastasis and invasion genes in a 
subpopulation of cells (n = 1273 cells) enriched for EMT and CIN genes (subpopulation 
‘M’) compared with the remaining subpopulations (n = 5548 cells) that were identified using 
graph-based unsupervised K-nearest neighbor embedding. c, Representative low-power field 
images (left) and numbers (right) of MDA-MB-231 cells which invaded through a collagen 
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membrane within 18 hours of culture. Bars represent mean ± SD, Significance tested using 
two-sided Mann Whitney test, n = 10 high-power fields, 2 independent experiments. d, 
Representative images of MDA-MB-231 cells expressing MCAK or dnMCAK stained for β-
actin, Vimentin, and DNA scale bar 50-μm, n = 2 independent experiments. e, Single-cell 
correlation plots between CIN signature genes, canonical NF-κB and type I interferon target 
genes, n = 6,821 cells. e, Representative phase-contrast images of a wound-healing assay of 
cells MCAK, MCAK+mad2 or dnMCAK expressing MDA-MB-231 cells and MCAK cells 
treated with cGAMP, scale bar 800-μm, 4 experiments.
Extended Data Figure 7. CIN promotes in vitro invasion and migration
a, Left, representative phase contrast images of MDA-MB-231 cells in the wound area, 36-
hours after wound creation, 4 experiments. Right, length-to-width ratio of cells expressing 
different kinesin-13 proteins. Bars span the interquartile range, n = 100 cells, 2 independent 
experiments, significance tested using two-sided Mann Whitney test. b, Representative 
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MDA-MB-231 cells stained for β-catenin (anti-β-catenin antibody) or DNA (DAPI). 
Changes in β-catenin are seen upon alteration of CIN; enriched at cell-to-cell junctions in 
MCAK expressing cells but cytoplasmic and nuclear in dnMCAK expressing cells, scale bar 
30-μm, 2 experiments. c, Above, Phase-contrast images of a wound-healing assay of cells 
expressing kinesin-13 proteins, scale bar 800-μm, 2 experiments. Bottom, Wound area 
(normalized to the 0h time point) 24h and 45h after wound creation, bars represent mean ± 
SD, n = 4 experiments, significance tested using two-sided t-test. d, Above, Low-power field 
images of MDA-MB-231 cells that have migrated through a polycarbonate membrane 
containing 8-μm pores within 18 hours of culture. Below, Normalized O.D. of cells scraped 
from the bottom of the membrane, bars represent mean ± s.e.m., significance tested using 
two-sided t-test, n = 3 experiments. e–f, Left, Number of MDA-MB-231 cells that have 
successfully invaded through a collagen basement membrane 24 hours after plating. Bars 
represent mean ± SD, n = 20 high power fields from 2 independent experiments, 
significance tested using two-sided Mann-Whitney test. Right, representative images from 
high-power fields, 2 independent experiments. g, i, Representative time-lapse fluorescence 
and phase-contract image sequences of control cells expressing NLS-GFP undergoing 
unconfined migration (g) or going through 1×5 μm2 constrictions (i). Scale bar 20-μm. 
Arrows in (g) indicate cytoplasmic NLS-GFP. Arrows in (i) indicate formation of nuclear 
protrusion and subsequently fragment during confined migration, 3 independent 
experiments. h, j, The probability of primary nuclear rupture during unconfined conditions 
(h, top) or after migration through 1×5 μm2 wide constrictions (j, top). The number of cells 
migrating through more than one 1-μm wide constrictions (j, bottom) and the duration of 
nuclear rupture (h, bottom) as measured by the length of time in which NLS-GFP signal is 
observed in the cytosol. Bars represent mean ± s.e.m., n = 3 independent experiments 
(except for unconfined rupture probability – 2 independent experiments) encompassing 390–
665 (h) and 150–336 (j) cells observed during unconfined and confined migration, 
respectively, significance tested using two-sided t-test.
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Extended Data Figure 8. CIN generates micronuclei and cytosolic DNA
a–b, Percentage of micronuclei in samples depicted in Figure 3c–d: injected cells (blue), 
first-passage cells derived from primary tumors (green), or metastases (orange denotes 
spontaneous metastases arising from primary tumors, red denotes metastases obtained from 
direct intracardiac implantation). Bars represent mean ± s.e.m., n = 10 high-power fields 
encompassing 500–1500 cells/sample, 3 independent experiments, * p < 0.05 and denotes 
samples with higher missegregation rates than the injected lines, # p < 0.05 and denotes 
samples with lower missegregation rates than the injected lines, ** p < 0.05 and it denotes 
significant differences between metastases and matched primary tumors from the same 
animals, two-tailed t-test. c, Correlation between the percentage of cells exhibiting evidence 
of chromosome missegregation and percentage of micronuclei in all injected cell lines as 
well as cells derived from primary tumors and metastases. Data points represent mean ± 
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s.e.m., n = 44 samples. d–f, Representative images of cells stained for DNA (DAPI), 
cytosolic single-stranded DNA (ssDNA) (d), Dnase2 (RFP reporter) (e), or cytosolic double-
stranded DNA (dsDNA) (f), scale bar 20-μm, arrows in e denote Dnase2 expressing cell, 2 
independent experiments. g, Representative images of dnMCAK expressing cells treated 
with ssDnase or dsDnase for 10 min. after selective plasma membrane permeabilization 
(using 0.02% saponin) stained for DNA (DAPI) and cytosolic dsDNA, scale bar 20-μm, one 
experiment. h, Representative images of dnMCAK expressing cells stained for mitochondria 
(using anti-CoxIV antibody), DNA (DAPI) or for cytosolic DNA (using anti-dsDNA 
antibody), scale bar 20-μm, 2 independent experiments. i, Immunoblots of lysates from cells 
expressing different kinesin-13 proteins, control or STING shRNA, β-actin used as a loading 
control. j, Normalized ratio of phosphorylated p52-to-p100 (left) and p100-to-total p100 
(right) protein levels. Bars represent mean ± s.e.m., n = 5 independent experiments.
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Extended Data Figure 9. Alternative response to cytosolic DNA in cancer cells
a–d, Representative images of MDA-MB-231 cells stained for DNA (DAPI), and for p65 
(a), IRF3 (b), or RelB (c–d). Images were individually contrast-enhanced to emphasize 
nuclear versus cytosolic localization of p65, IRF3, and RelB. For quantitative comparisons 
of the identical images, please refer to Supplementary Figure 3. Arrows (c–d) point to RelB-
positive nuclei, scale bars, 20-μm, 3 independent experiments. e, Immunoblots of 
fractionated lysates. a-tubulin and Lamin B2 were used as loading controls for the 
cytoplasmic and nuclear fractions, respectively, 3 independent experiments. f, h, Interferon-
β levels in conditioned media from DLD-1 cells (f) MDA-MB-231 or HEK293 cells with 
and without cGAMP addition (h). Bars represent mean ± s.e.m. n = 3 experiments, 
significance tested using one-sided Mann-Whitney test. g, i, Relative levels of interferon 
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responsive genes obtained by RT-qPCR, DLD-1 cells (g) normalized to untreated conditions 
or MDA-MB-231 cells (i) normalized to control cells. Bars represent mean ± SD n = 3 
experiments, significance tested using 2-sided t-test. j, Immunoblots of lysates of dnMCAK 
expressing cells that also co-express control shRNA or shRNAs targeting components of 
cytosolic DNA sensing or the noncanonical NF-κB pathway. shRNA hairpins are numbered 
in ascending order based on the efficiency of the protein knockdown, 2 independent 
experiments.
Extended Data Figure 10. Effect of cytosolic DNA sensing pathways on prognosis
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a, Distant metastasis-free survival (DMFS), Relapse-free survival (RFS) and Progression-
free survival (PFS) of breast and lung cancer patients, respectively stratified based on their 
expression of NF-κB and interferon pathways, significance tested using two-sided log-rank 
test. b, Disease-specific survival of mice injected with dnMCAK expressing MDA-MB-231 
cells co-expressing either control shRNA, STING shRNA, NFKB2 shRNA, or RelB shRNA 
n = 35, 16, 19, and 20 mice in the control, STING shRNA, NFKB2 shRNA, and RelB 
shRNA groups respectively, significance tested using two-sided log-rank test. c, Number of 
MDA-MB-231 cells expressing shRNA targeting genes belonging to the DNA sensing or 
noncanonical NF-κB pathways that invaded through a collagen membrane within 24 hours 
of culture. Bars represent mean ± SD, ** p < 0.0001, two-sided Mann Whitney test, n = 20 
high-power fields, 2 independent experiments. d, Number of different normal tissues 
(vascular, neuronal, or soft tissues) invaded by orthotopically transplanted tumors. Bars 
represent mean ± s.e.m., *p < 0.05, two-tailed t-test, n = 13 tumors (CIN-high), 20 tumors 
(noncanonical NF-κB depleted), 19 tumors (cGAS-STING depleted). e, Oncoprints showing 
genomic alterations in STING (TMEM173) and cGAS (MB21D1) in breast and lung 
cancers from the TCGA database.
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Figure 1. Human metastases enrich for CIN
a, wGII of matched primary tumors (P) and brain metastases (M), n = 79 patients. b–c, 
Karyotype probability density (b) and chromosomal aberrations (c) in 983 primary tumor 
and 186 metastatic breast cancer clones. d, Images of a head and neck squamous cell 
carcinoma cells undergoing anaphase. Arrows point to chromosome missegregation, scale 
bar 5-μm. Right, Chromosome missegregation in tumors from patients with (N+, n = 22 
patients) or without (N-, n = 18 patients) clinically detectable lymph node metastases. Boxes 
represent median ± interquartile range, confidence intervals denote 10th–90th percentile (a, 
c–d), significance tested using two-sided Wilcoxon matched-pairs signed rank test (a) and 
two-sided Mann Whitney test (b–d).
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Figure 2. CIN is a driver of metastasis
a, Anaphase cells stained for centromeres and DNA, scale bar 5-μm. b, Chromosome 
missegregation in cells expressing kinesin-13 proteins. Bars represent mean ± SD, n = 150 
cells. c, Whole animal bioluminescence (BLI) 7 weeks after intracardiac injection of MDA-
MB-231 cells. Bars represent the median, n = 12 (MCAK+Mad2), 20 (MCAK), 7 (Kif2b), 9 
(control), 9 (Kif2a), 8 (dnMCAK) mice. d, Ex-vivo BLI of organs with metastases from 
MDA-MB-231 cells expressing dnMCAK. e, Disease-specific survival of mice injected with 
CIN-high (n = 33) or CIN-low (n = 20) MDA-MB-231. Significance tested using two-sided 
t-test (b), two-sided Mann Whitney test (c), and two-sided log-rank test (e) n = 3 (a–b) and 5 
(d) independent experiments. Throughout the manuscript, pairwise comparisons between 
individual CIN-low and CIN-high conditions are smaller than the stated p value.
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Figure 3. Opposing roles for CIN in primary tumors and metastases
a, Experimental schema. b–d, Chromosome missegregation in injected cells (blue), cells 
derived from primary tumors (green), metastases (met) arising spontaneously (orange) or 
after intracardiac injection (red). ST, soft tissue. Bars represent mean ± SD, n = 150 cells, 3 
independent experiments, *p < 0.05, #p < 0.05, **p < 0.05 denote samples with higher or 
lower chromosome missegregation than the injected lines, and spontaneous metastases with 
higher missegregation than matched primary tumors, respectively. Significance tested using 
two-sided t-test (b–d).
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Figure 4. CIN enriches for mesenchymal cell traits
a, Heatmap showing expression of EMT genes in 6,821 MCAK, Kif2b, and dnMCAK 
expressing MDA-MB-231 cells. b, Above, t-stochastic neighbor embedding (tSNE) 
projection of all cells in a. Below, Heatmap of normalized enrichment score (NES) for 
pathways with an FDRq < 0.05 based on GSEA using one-sided Weighted Smirnov-
Kolmogorov test on subpopulations identified using Phenograph. Boxes outline populations 
with mutually exclusive transcriptional profiles.
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Figure 5. CIN generates cytosolic DNA
a, Heatmap showing gene-gene correlations in 6,821 cells and HALLMARK gene sets 
significantly enriched in Module 2, one-sided Weighted Smirnov-Kolmogorov test. b, Top 
right, normalized expression level of key gene signatures in 6,821 MCAK, Kif2b, and 
dnMCAK expressing MDA-MB-231 cells. Bottom left, Correlation plots for key gene 
signatures. c, A primary nucleus and a micronucleus stained for centromeres and DNA, scale 
bar 5-μm. d–e, Percentage of micronuclei cells expressing various kinesin-13 proteins (d) or 
in cells derived from 10 primary tumors and 28 metastases (e). n = 20 high-power fields per 
sample (d) or average values derived from 10 high-power fields per sample (e). f, MCAK 
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and dnMCAK expressing MDA-MB-231 cells stained using DAPI and anti-dsDNA 
antibody, scale bar 20-μm. g, Cytosolic-to-nuclear DNA ratios in CIN-high (n = 5) and CIN-
low (n = 4) MDA-MB-231 (n = 5) and H2030 (n = 4) cells. h, Left, DLD-1 cells stained for 
DNA and hybridized to chromosome-specific FISH probes, scale bar 5-μm. Right, 
Percentage of cells containing micronuclei or small cytosolic DNA fragments (n >500 cells 
per condition). i, MDA-MB-231 cells stained using DAPI, anti-dsDNA antibody, or 
mCherry-Lamin B2 (arrow), scale bar 10-μm. Bars represent median ± inter-quartile range 
(d–e), mean ± SD (g), mean ± sem (h). n = 6 (c–d), 3 (e–f, h), 1 (g) and 2 (i) independent 
experiments. Significance tested using two-sided Mann-Whitney test (d–e) or two-sided t-
test (g–h), * p <0.05.
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Figure 6. Metastasis from a cytosolic DNA response
a, MDA-MB-231 cells stained for DNA and cGAS, scale bar 5-μm. b, Percentage of 
micronuclei with (cGAS+) or without (cGAS-) cGAS localization, n = 200 cells. c, Cells 
stained for DNA and STING, scale bar 20-μm. d, Percentage of MDA-MB-231 cells with 
nuclear RelB, n = 150 cells. e, Average z-normalized expression of CIN-responsive 
noncanonical NF-κB target genes in breast cancer patients with low (<30th percentile, n = 
330) or high (>30th percentile, n = 332) CIN gene expression signature. f–g, Photon flux 
(p/s) of whole animals after intracardiac injection with MDA-MB-231 cells expressing 
control shRNA, STING shRNA (f), RelB shRNA (g) or NFKB2 shRNA (g), n = 9, 7, and 9 
mice for the control, STING shRNA1, and STING shRNA2 groups, respectively (f), n = 22, 
10, 10, 10, and 9 mice for the control, RelB shRNA1, RelB shRNA2, NFKB2 shRNA1, and 
NFKB2 shRNA2 groups, respectively (g). Bars represent mean ± SD (b, d), median ± 
interquartile range with bars spanning 10th–90th percentile (e), median (f–g), significance 
tested using two-sided t-test (b, d), two-sided Mann Whitney test (e–g), n = 4 (a–b), and 3 
(c–d) independent experiments.
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